TAK Financials
Takeda Pharmaceutical Co Ltd - Financial statements & key metrics
Stock Price
$17.82
Market Cap
$56.17B
P/E Ratio
80.8
EPS
$0.22
Income Statement Highlights
Most Recent Quarter: 2025-03-31
Revenue
$4.58T
Gross Profit
$3.00T
Operating Income
$342.59B
Net Income
$107.93B
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$14.25T
Total Liabilities
$7.31T
Shareholders Equity
$6.94T
Cash & Equivalents
$385.11B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$1.06T
CapEx
$200.79B
Free Cash Flow
$856.39B
Profitability Metrics
Gross Margin
65.5%
Operating Margin
0.1%
Net Margin
0.0%
ROE
0.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is TAK revenue?
TAK's most recent quarterly revenue was $4.58T. Annual revenue can be calculated by summing the four most recent quarters.
Is TAK profitable?
TAK reported a profit of $107.93B in the most recent quarter. The net profit margin is 0.0%.
What is TAK market cap?
TAK has a market capitalization of $56.17B, making it a large-cap stock.
Does TAK have debt?
View TAK's balance sheet for debt information.
What is TAK cash flow?
TAK's most recent quarterly free cash flow was $856.39B.